Expanding Clinical Presentations Due to Variations in THOC2 mRNA Nuclear Export Factor
Raman Kumar, Elizabeth E. Palmer, Alison Gardner, Renée Carroll, Siddharth Banka, Ola Abdelhadi, Dian Donnai, Ype Elgersma, Cynthia J. Curry, Alice Gardham, Mohnish Suri, Rishikesh Malla, Lauren Brady, Mark A. Tarnopolsky, Dimitar N. Azmanov, Vanessa Atkinson, Michael T. Black, Gareth Baynam, Lauren Dreyer, Robin Z. Hayeems, Christian R. Marshall, Gregory Costain, Marja W. Wessels, Júlia Baptista, James Drummond, Melanie Leffler, Michael Field, Jozef Gécz
Abstract
Multiple TREX mRNA export complex subunits (e.g., THOC1, THOC5, THOC7, THOC6) have now been implicated in neurodevelopmental disorders (NDDs), neurodegeneration and cancer. We previously implicated missense and splicing-defective THOC2 variants in NDDs and a broad range of other clinical features. Here we report 10 individuals from 9 families with rare missense THOC2 variants including the first case of a recurrent variant (p.Arg77Cys), and an additional individual with an intragenic THOC2 microdeletion (Del-Ex37-38). Ex vivo missense variant testing and patient-derived cell line data from current and published studies show 9 of the 14 missense THOC2 variants result in reduced protein stability. The splicing-defective and deletion variants result in a loss of small regions of the C-terminal THOC2 RNA binding domain. Interestingly, reduced stability of THOC2 variant proteins has a flow on effect on the stability of the multiprotein TREX complex and specifically the other NDD-associated THOC subunits. Our current, expanded cohort refines the core phenotype of THOC2 NDDs to language disorder and/or ID, with a variable severity, and disorders of growth. A subset of affected individuals' have severe-profound ID, persistent hypotonia and respiratory abnormalities. Further investigations to elucidate the pathophysiological basis for this severe phenotype are warranted.